Physician profile
Natalie Warner
NPI 1114534567
$5,857.56
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,474 · 2022: $3,197 · 2023: $1,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,136 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.30 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,592.38 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $1,059.08 | 2021 | |
| Ucb, INC. | $817.32 | 2021-2023 | Briviact, Nayzilam |
| Biohaven Pharmaceutical Holding Company LTD. | $601.13 | 2022 | |
| Biogen, INC. | $401.33 | 2021-2023 | Vumerity |
| Emd Serono, INC. | $330.47 | 2022-2023 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $327.84 | 2022-2023 | Ultomiris |
| Lilly USA, LLC | $155.81 | 2021-2022 | |
| Kyowa Kirin, INC. | $143.17 | 2022-2023 | Nourianz |
| Sumitomo Pharma America, INC. | $100.46 | 2023 | Aptiom |
| Abbvie INC. | $97.68 | 2023 | |
| Acorda Therapeutics, INC | $71.18 | 2022 | |
| Argenx US, INC. | $56.90 | 2023 | Vyvgart |
| Tanabe Pharma America, INC. | $26.56 | 2022 | |
| Neurocrine Biosciences, INC. | $23.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.48 | 2023 | |
| Acadia Pharmaceuticals INC | $15.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.